Not registered yet? Get a free account.

Sign Up
search icon cancel icon

FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED

Active
Updated: 05 Sep 2025

This company's line of business includes the manufacturing, fabricating, or processing of drugs in pharmaceutical preparations for human or veterinary use.

Franco-Indian Pharmaceuticals Private Limited, is an unlisted private company incorporated on 01 May, 1959. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 2.00 cr and the total paid-up capital is INR 46.25 lac.

Read more

Subscription Plans
Industry and products
Manufacturing of Pharmaceuticals
  • FIP, Diabetix
Company size
Auth Capital
₹ 2.0 Cr
Paidup Capital
₹ 46.2 L
Revenue
₹ 750-1000 cr
# Key metrics of Franco-Indian Pharmaceuticals - All rupee values in INR crores. Based on March 2023 numbers. | Metric | Value | Change | |---|---|---| | Auth Capital | ₹ 2.0 Cr | | | Paidup Capital | ₹ 46.2 L | | | Revenue | ₹ 750-1000 cr | | | Total Revenue | Details available with Tofler Pro subscription | 3.15% | | EBITDA | Details available with Tofler Pro subscription | 22.09% | | Net Profit | Details available with Tofler Pro subscription | 30.66% | | Networth | Details available with Tofler Pro subscription | 17.09% | | Borrowings | Details available with Tofler Pro subscription | 0.0% | | Assets | Details available with Tofler Pro subscription | 6.95% | | Gross Margin | Details available with Tofler Pro subscription | -0.27 | | Operating Margin | Details available with Tofler Pro subscription | 1.83 | | Net Profit Margin | Details available with Tofler Pro subscription | 1.57 | | Return on Equity | Details available with Tofler Pro subscription | 2.53 | | ROCE | Details available with Tofler Pro subscription | 7.11 | | Debt to Equity | Details available with Tofler Pro subscription | -0.01 |
Key Metrics

** All rupee values in INR crores. Based on March 2023 numbers.

Total Revenue
3.15%
₹ GET PRO
EBITDA
22.09%
₹ GET PRO
Net Profit
30.66%
₹ GET PRO
Networth
17.09%
₹ GET PRO
Borrowings
-
₹ GET PRO
Assets
6.95%
₹ GET PRO
Gross Margin
-0.27
GET PRO %
Operating Margin
1.83
GET PRO %
Net Profit Margin
1.57
GET PRO %
Return on Equity
2.53
GET PRO %
ROCE
7.11
GET PRO %
Debt to Equity
-0.01
GET PRO
Sales
Mar 2023
Net worth
Mar 2023

Locations

indian flag India (28)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Director Santosh Mohan Chavan 09097972 4 years
Director Jagdish Purushottamdas Mehta 00053296 11 years
Managing Director Pascal Postel
Shareholder
00026853 28 years
Director Lalsa Balgovind Yadav 00055974 20 years
Director Ajit Anant Mangalvede 10140076 2 years
Director Alexandre Johan Postel 03588038 3 years
Additional Director Errol James Desouza 00053201 3 years

Financial Highlights

** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%
** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
FRANCO INDIAN RESEARCH PRIVATE LIMITED
Active
1.0 L 2 Tamil Nadu
PRINCEPS PHARMACEUTICALS PRIVATE LIMITED
Active
1.0 L 2 Tamil Nadu
FRANCO INDIAN MEDICARE PVT LTD
Active
1.0 L 2 West Bengal
FRANCO INDIAN THERAPEUTICS PVT. LTD.
Active
1.0 L 2 West Bengal
LABORATOIRES GRIFFON PRIVATE LIMITED
Active
32.1 L 3 West Bengal
FRANCO-INDIAN HOLDINGS PRIVATE LIMITED
Active
7.4 Cr 2 Maharashtra
WARDEX PHARMACEUTICALS PRIVATE LIMITED
Active
42.0 L 4
MEDIBEST INVESTMENTS PRIVATE LIMITED
Amalgamated
11.5 L 2 Maharashtra
PHARMABEST INVESTMENTS PRIVATE LIMITED
Amalgamated
11.5 L 1 Maharashtra
CURABEST INVESTMENTS PRIVATE LIMITED
Amalgamated
11.5 L 2 Maharashtra
FRANCO-INDIAN REMEDIES PRIVATE LIMITED
Active
14.9 L 1 Tamil Nadu

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

U24239MH1959PTC011347

PAN

AAACF1794M

Incorporation

1959, 66.4 years

Company Email

sbrahane@francoindian.com

Paid up Capital

₹ 46.2 L

Authorised Capital

₹ 2.0 Cr

AGM

Sep 2024

Type

Private
Others

FAQ - FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED

What is the incorporation date of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The incorporation date of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is 01 May, 1959

What is the authorized share capital of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The authorized share capital of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 2.0 Cr.

What is the paid-up capital of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The paid-up capital of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 46.2 L.

What is the registered address of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The registered address of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is 20 DR E MOSES ROAD, MUMBAI, Maharashtra, India, 400011 - 400011

What is the CIN number of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED?

plus icon

The CIN number of FRANCO-INDIAN PHARMACEUTICALS PRIVATE LIMITED is U24239MH1959PTC011347.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More